Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1992-06-01 (33 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CANET-EN-ROUSSILLON (66140), Pyrenees-Orientales
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LA CANETOISE : revenue, balance sheet and financial ratios
PHARMACIE LA CANETOISE is a French company
founded 33 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CANET-EN-ROUSSILLON (66140),
this company of category PME
shows in 2025 a net income positive of 38 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LA CANETOISE (SIREN 387756877)
Indicator
2025
2024
2023
2021
Revenue
N/C
N/C
N/C
N/C
Net income
37 636 €
113 088 €
231 556 €
119 839 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE LA CANETOISE generates positive net income of 38 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 120 k€ -> 38 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
37 636 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 194%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
193.839%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
24.193%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE LA CANETOISE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2023
2024
2025
Debt ratio
710.467
176.768
187.077
193.839
Financial autonomy
8.964
29.292
26.091
24.193
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
193.842025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of PHARMACIE LA CANETOISE (193.84) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
24.19%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch
In 2025, the financial autonomy of PHARMACIE LA CANETOISE (24.2%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 259.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
259.609
Liquidity indicators evolution PHARMACIE LA CANETOISE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2023
2024
2025
Liquidity ratio
118.158
245.491
189.457
259.609
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
259.612025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent+8 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE LA CANETOISE (259.61) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE LA CANETOISE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE LA CANETOISE is estimated at
597 852 €
(range 405 705€ - 938 112€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
405k€597k€938k€
597 852 €Range: 405 705€ - 938 112€
NAF 5 année 2025
Valuation method used
Net Income Multiple
37 636 €
×
15.9x
=597 852 €
Range: 405 705€ - 938 113€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LA CANETOISE with other companies in the same sector:
Frequently asked questions about PHARMACIE LA CANETOISE
What is the revenue of PHARMACIE LA CANETOISE ?
The revenue of PHARMACIE LA CANETOISE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LA CANETOISE profitable?
Yes, PHARMACIE LA CANETOISE generated a net profit of 38 k€ in 2025.
Where is the headquarters of PHARMACIE LA CANETOISE ?
The headquarters of PHARMACIE LA CANETOISE is located in CANET-EN-ROUSSILLON (66140), in the department Pyrenees-Orientales.
Where to find the tax return of PHARMACIE LA CANETOISE ?
The tax return of PHARMACIE LA CANETOISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LA CANETOISE operate?
PHARMACIE LA CANETOISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart